Home
|
Glossary
|
Site Map
|
Contact Us
about us
product pipeline
technology
clinical trials
investors & news
careers
•
Management
•
Board of Directors
•
Collaborations
•
Brentuximab Vedotin (SGN-35)
•
Lintuzumab (SGN-33)
•
Dacetuzumab (SGN-40)
•
SGN-70
•
SGN-75
•
ASG-5ME
•
Preclinical Programs
•
Scientific Publications
•
ADC Technology
•
SEA Technology
•
Scientific Publications
By Program:
•
Brentuximab Vedotin (SGN-35)
•
Lintuzumab (SGN-33)
•
Dacetuzumab (SGN-40)
•
SGN-70
•
SGN-75
•
ASG-5ME
By Indication:
•
Hodgkin Lymphoma
•
Non-Hodgkin Lymphoma
•
Multiple Myeloma
•
Leukemia/MDS
•
Autoimmune
•
Solid Tumors
•
Press Releases
•
Stock Performance
•
SEC Filings
•
Webcasts & Events
•
Scientific Publications
•
Corporate Governance
•
Analyst Coverage
•
Financial Reports
•
Investor FAQ
•
Information Request
•
Benefits
•
Living in the Area
•
Job Opportunities
INVESTORS & NEWS
•
Press Releases
•
Stock Performance
•
SEC Filings
•
Webcasts & Events
•
Scientific Publications
•
Corporate Governance
•
Analyst Coverage
•
Financial Reports
•
Investor FAQ
•
Information Request
UPCOMING EVENTS
There are currently no events scheduled.
PAST EVENTS
Date
Title
8/10/2010 9:30 AM ET
Canaccord Genuity 30th Annual Growth Conference
7/27/2010 5:00 PM ET
Second Quarter 2010 Financial Results Conference Call
6/15/2010 3:05 PM PT
31st Annual Goldman Sachs Healthcare Conference
6/8/2010 1:00 PM ET
Jefferies 2010 Global Life Sciences Conference